Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Randomized, Single-arm, Phase Ⅰ Clinical Trial to Evaluate the Safety of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried Vaccinated With Different Immunization Schedule in People Aged 10-60 Years
Authors not listed
Ab&B Bio-tech Co., Ltd.JS · 2023
Abstract
The safety of different immunization procedures of rabies vaccine (human diploid cells) was investigated by successive design of different age groups. The two vaccination procedures were carried out successively according to the age of the subjects from the oldest to the youngest. The first 40 subjects aged 18-60 were randomly assigned to the Essen experimental group and the Zagreb experimental group in a 1:1 ratio, all of whom received the experimental vaccine. After the observation of the third dose of vaccine for at least 7 days, the preliminary safety assessment was conducted. If the incidence of grade 3 or higher adverse events associated with the experimental vaccination did not exceed 15%, and no vaccination-related death or life-threatening serious adverse events occurred, 40 subjects aged 10-17 years old were enrolled, and 40 subjects aged 10-17 years old were randomly assigned to the Essen and Zagreb trials in a 1:1 ratio. Conduct safety studies.
Safety study: All adverse events that occurred within 30 minutes, 0-7 days, and 0-30 days after each dose were collected, as well as all serious adverse events that occurred within 6 months after the first dose. Blood and urine samples were collected before the first dose and 3 days after the first dose, and blood routine, blood biochemical and urine routine tests were performed for safety assessment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Anonymous. (2023). A Randomized, Single-arm, Phase Ⅰ Clinical Trial to Evaluate the Safety of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried Vaccinated With Different Immunization Schedule in People Aged 10-60 Years. <em>Ab&B Bio-tech Co., Ltd.JS</em>. https://clinicaltrials.gov/study/NCT06132789
Vancouver
Anonymous. A Randomized, Single-arm, Phase Ⅰ Clinical Trial to Evaluate the Safety of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried Vaccinated With Different Immunization Schedule in People Aged 10-60 Years. Ab&B Bio-tech Co., Ltd.JS. 2023.
BibTeX
@misc{anon2023ARando,
title = {A Randomized, Single-arm, Phase Ⅰ Clinical Trial to Evaluate the Safety of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried Vaccinated With Different Immunization Schedule in People Aged 10-60 Years},
author = {Anonymous},
journal = {Ab&B Bio-tech Co., Ltd.JS},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 2023
Open access · US-GOV
A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Tolerability of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells) in People Aged 18 Years and Above.
Ab&B Bio-tech Co., Ltd.JS 2026
Open access · US-GOV
A Phase III, Randomized, Blinded, and Homologous Vaccine-Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of the Rabies Vaccine (Human Diploid Cell), Freeze-dried, Vaccinated With Different Immunization Schedules in a Population Aged 10 to 60 Years
Sinovac Biotech Co., Ltd 2025
Open access · US-GOV
Randomized, Double-blind, Controlled Phase I/II Clinical Trial on the Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell) in Healthy Adults and Children Aged 6 Months to 12 Years.
Liaoning Chengda Biotechnology CO., LTD 2025
Open access · US-GOV
Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations
SK Chemicals Co., Ltd. 2014
Open access · US-GOV
A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess the Immunogenicity and Safety of Quadrivalent Inactivated Cell Culture-derived Influenza Vaccine in Adults and Elderly Subjects
Institute of Medical Biology, Chinese Academy of Medical Sciences 2023
Open access · US-GOV